In hepatocellular carcinoma (HCC), hepatocyte-specific NF-κB activation inhibits chemically induced tumorigenesis by suppressing JNK-driven inflammation and necrosis [402–405]. Here, MAPK8 is linked to hepatocellular carcinoma.